Neumora Therapeutics, Inc. (NMRA) vs Spruce Biosciences, Inc. (SPRB)

Neumora Therapeutics, Inc. and Spruce Biosciences, Inc. are both Biotechnology companies. Neumora Therapeutics, Inc. and Spruce Biosciences, Inc. are of similar size ($140.9M and $135.3M). Across the 10 metrics below, Spruce Biosciences, Inc. leads on 9 and Neumora Therapeutics, Inc. on 1.

Valuation

Metric NMRA SPRB Biotechnology median
P/E n/m n/m 7.88
P/S n/m 24.12 11.47
P/B 2.83 1.41 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 5.95 10.73
Earnings yield (180.88%) (81.65%) (28.84%)
Free cash flow yield (143.21%) (36.12%) (23.03%)

Profitability

Metric NMRA SPRB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (187.11%) (105.98%) (57.72%)
Return on assets (121.89%) (82.38%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NMRA SPRB Biotechnology median
Revenue growth (TTM) — (51.32%) 5.64%
EPS growth (last fiscal year) 5.23% 47.59% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NMRA SPRB Biotechnology median
Debt to equity 1.19 0.08 0.00
Current ratio 4.50 9.23 4.73
Net debt to EBITDA 0.53 1.34 0.96

Dividend

Metric NMRA SPRB Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric NMRA SPRB Biotechnology median
Market cap 135.29m 140.88m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack